Sagimet Biosciences Inc.
Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.
On December 28, 2023, Anthony Rimac, the Chief Financial Officer of Sagimet Biosciences Inc. (the “ Company ”) provided notice of his intent to resign effective January 31, 2024.
On January 31, 2024, the board of directors (the “ Board ”) of the Company appointed Joseph Oriti as Interim Principal Financial Officer and Interim Principal Accounting Officer, effective as of February 1, 2024 (the “ Effective Date ”).
Extracted from this filing and checked against the source text.
Anthony Rimac resigned as Chief Financial Officer at Sagimet Biosciences Inc..
On December 28, 2023, Anthony Rimac, the Chief Financial Officer of Sagimet Biosciences Inc. (the “ Company ”) provided notice of his intent to resign effective January 31, 2024.View on SEC.gov
Joseph Oriti was appointed as Interim Principal Financial Officer and Interim Principal Accounting Officer at Sagimet Biosciences Inc..
On January 31, 2024, the board of directors (the “ Board ”) of the Company appointed Joseph Oriti as Interim Principal Financial Officer and Interim Principal Accounting Officer, effective as of February 1, 2024 (the “ Effective Date ”).View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.